Reliq Health Technologies Inc. (TSX VENTURE:RHT)(OTCQB:RQHTF) (“Reliq” or the “Company“), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has been accepted into the National Health Service (the “NHS“) United Kingdom’s (the “UK’s“) Test Beds program and will begin piloting its virtual care technology with a London-area hospital in Q4 2016.
“We are very excited to be piloting Reliq’s community care platform in the UK. Our technology is strongly aligned with the NHS England’s ongoing initiative to improve the management of long term conditions in the community,” said Dr. Lisa Crossley, CEO of Reliq Health. “Our platform uses a high tech, low touch approach to provide high quality healthcare in the home, reducing exacerbations and disease-related complications, decreasing healthcare costs and enhancing patient and family satisfaction. We look forward to participating in the NHS Test Beds program to demonstrate the value of Reliq Health’s technology to patients, caregivers and the health system in the UK.”
The pilot will focus on two of the most common chronic conditions in the UK, congestive heart failure (the “CHF“) and diabetes. Currently there are over 15 million people in England living with at least one long-term health condition. In addition to the impact on people’s lives, long-term condition management accounts for half of all General Practitioner appointments and 70% of hospital bed days in the UK. Reliq Health’s proprietary hardware and software supports patients and their caregivers in the home, providing remote vitals monitoring with alerts to clinicians as needed, audible reminders to improve patient compliance with prescribed medication regimens and lifestyle changes, tailored patient education and secure communication with the entire care team.
ON BEHALF OF THE BOARD,
Dr. Lisa Crossley, CEO and Director